282 related articles for article (PubMed ID: 26000818)
1. Oligodendrocytes and Alzheimer's disease.
Cai Z; Xiao M
Int J Neurosci; 2016; 126(2):97-104. PubMed ID: 26000818
[TBL] [Abstract][Full Text] [Related]
2. Dynamic changes in myelin aberrations and oligodendrocyte generation in chronic amyloidosis in mice and men.
Behrendt G; Baer K; Buffo A; Curtis MA; Faull RL; Rees MI; Götz M; Dimou L
Glia; 2013 Feb; 61(2):273-86. PubMed ID: 23090919
[TBL] [Abstract][Full Text] [Related]
3. Oligodendroglial Cells in Alzheimer's Disease.
Butt AM; De La Rocha IC; Rivera A
Adv Exp Med Biol; 2019; 1175():325-333. PubMed ID: 31583593
[TBL] [Abstract][Full Text] [Related]
4. Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer's disease.
Vanzulli I; Papanikolaou M; De-La-Rocha IC; Pieropan F; Rivera AD; Gomez-Nicola D; Verkhratsky A; Rodríguez JJ; Butt AM
Neurobiol Aging; 2020 Oct; 94():130-139. PubMed ID: 32619874
[TBL] [Abstract][Full Text] [Related]
5. White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes.
Nasrabady SE; Rizvi B; Goldman JE; Brickman AM
Acta Neuropathol Commun; 2018 Mar; 6(1):22. PubMed ID: 29499767
[TBL] [Abstract][Full Text] [Related]
6. Alterations of myelin morphology and oligodendrocyte development in early stage of Alzheimer's disease mouse model.
Wu Y; Ma Y; Liu Z; Geng Q; Chen Z; Zhang Y
Neurosci Lett; 2017 Mar; 642():102-106. PubMed ID: 28174059
[TBL] [Abstract][Full Text] [Related]
7. Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target.
Desai MK; Mastrangelo MA; Ryan DA; Sudol KL; Narrow WC; Bowers WJ
Am J Pathol; 2010 Sep; 177(3):1422-35. PubMed ID: 20696774
[TBL] [Abstract][Full Text] [Related]
8. Disease-Associated Oligodendrocyte: New Player in Alzheimer's Disease and CNS Pathologies.
Chen P; Guo Z; Zhou B
J Integr Neurosci; 2023 Jul; 22(4):90. PubMed ID: 37519162
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease as homeostatic responses to age-related myelin breakdown.
Bartzokis G
Neurobiol Aging; 2011 Aug; 32(8):1341-71. PubMed ID: 19775776
[TBL] [Abstract][Full Text] [Related]
10. Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease.
Bartzokis G
Neurobiol Aging; 2004 Jan; 25(1):5-18; author reply 49-62. PubMed ID: 14675724
[TBL] [Abstract][Full Text] [Related]
11. Oligodendrocyte progenitor cells in Alzheimer's disease: from physiology to pathology.
Zou P; Wu C; Liu TC; Duan R; Yang L
Transl Neurodegener; 2023 Nov; 12(1):52. PubMed ID: 37964328
[TBL] [Abstract][Full Text] [Related]
12. Myelin repair in Alzheimer's disease: a review of biological pathways and potential therapeutics.
Hirschfeld LR; Risacher SL; Nho K; Saykin AJ
Transl Neurodegener; 2022 Oct; 11(1):47. PubMed ID: 36284351
[TBL] [Abstract][Full Text] [Related]
13. Multiscale network modeling of oligodendrocytes reveals molecular components of myelin dysregulation in Alzheimer's disease.
McKenzie AT; Moyon S; Wang M; Katsyv I; Song WM; Zhou X; Dammer EB; Duong DM; Aaker J; Zhao Y; Beckmann N; Wang P; Zhu J; Lah JJ; Seyfried NT; Levey AI; Katsel P; Haroutunian V; Schadt EE; Popko B; Casaccia P; Zhang B
Mol Neurodegener; 2017 Nov; 12(1):82. PubMed ID: 29110684
[TBL] [Abstract][Full Text] [Related]
14. Cdk5-mediated oligodendrocyte myelin breakdown and neuroinflammation: Implications for the link between Type 2 Diabetes and Alzheimer's disease.
Paul S; Bhardwaj J; Binukumar BK
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166986. PubMed ID: 38092158
[TBL] [Abstract][Full Text] [Related]
15. Focal demyelination in Alzheimer's disease and transgenic mouse models.
Mitew S; Kirkcaldie MT; Halliday GM; Shepherd CE; Vickers JC; Dickson TC
Acta Neuropathol; 2010 May; 119(5):567-77. PubMed ID: 20198482
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
17. White Matter and Neuroprotection in Alzheimer's Dementia.
Lorenzini L; Fernandez M; Baldassarro VA; Bighinati A; Giuliani A; Calzà L; Giardino L
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979414
[TBL] [Abstract][Full Text] [Related]
18. Myelin loss and oligodendrocyte pathology in white matter tracts following traumatic brain injury in the rat.
Flygt J; Djupsjö A; Lenne F; Marklund N
Eur J Neurosci; 2013 Jul; 38(1):2153-65. PubMed ID: 23458840
[TBL] [Abstract][Full Text] [Related]
19. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease.
Roher AE; Weiss N; Kokjohn TA; Kuo YM; Kalback W; Anthony J; Watson D; Luehrs DC; Sue L; Walker D; Emmerling M; Goux W; Beach T
Biochemistry; 2002 Sep; 41(37):11080-90. PubMed ID: 12220172
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer's disease and the protective role of BDNF.
Zota I; Chanoumidou K; Charalampopoulos I; Gravanis A
Glia; 2024 Apr; 72(4):809-827. PubMed ID: 38205694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
